Realistic expectations of prepulse inhibition in translational models for schizophrenia research

Psychopharmacology

Volumn 199, Issue 3, 2008, Pages 331-388

  Swerdlow, Neal R ^a   Weber, Martin ^a   Qu, Ying ^a   Light, Gregory A ^a   Braff, David L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Animal models; Antipsychotic; Dopamine; Prepulse inhibition; Schizophrenia; Sensorimotor gating; Startle

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; 5 (4 CYANOPHENYL) 2 [2 (2 METHYL 1 IMIDAZOLIDINYL)ETHYL]BENZOFURAN; 5,5 DIMETHYL 2 MORPHOLINEACETIC ACID; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; 8 [2 [(2,3 DIHYDRO 1,4 BENZODIOXIN 2 YL)METHYLAMINO]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE MESYLATE; ARIPIPRAZOLE; AS 057278; CANNABINOID 1 RECEPTOR ANTAGONIST; CHOLINESTERASE INHIBITOR; CLOMIPRAMINE; CP 809101; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR BLOCKING AGENT; F 15063; GUANYLATE CYCLASE INHIBITOR; HALOPERIDOL; ILOPERIDONE; JL 13; JP 1302; LAMOTRIGINE; LY 487379; MANGANESEDICHLORO(3,10,13,20,26 PENTAAZATETRACYCLO[20.3.1.0(4,9).0(14,19)] 1(26),22(23),24 HEXACOSATRIENE); MC 242; MUSCARINIC AGENT; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NICOTINIC RECEPTOR BLOCKING AGENT; NITRIC OXIDE SYNTHASE INHIBITOR; NT 69L; OLANZAPINE; PD 149163; PEROSPIRONE; PIMAVANSERIN; QF 2004B; QUETIAPINE; RIMONABANT; RISPERIDONE; SB 258741; SB 271046 A; SR 146131; SSR 181507; SSR 5504734; UNINDEXED DRUG; VOLINANSERIN; WAY 163909; ZOTEPINE;

BRAIN MAPPING; DISEASE COURSE; HUMAN; MEDICAL RESEARCH; MODEL; NEUROBIOLOGY; NONHUMAN; PHENOTYPE; PREPULSE INHIBITION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELIABILITY; REVIEW; SCHIZOPHRENIA; SENSORIMOTOR FUNCTION; STARTLE REFLEX; SYMPTOMATOLOGY;

ANIMALS; ANTIPSYCHOTIC AGENTS; DISEASE MODELS, ANIMAL; HUMANS; MODELS, PSYCHOLOGICAL; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STARTLE REACTION;

EID: 46649110318     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-008-1072-4     Document Type: Review

References (478)

1. Aasen I et al (2005) Sex effects in prepulse inhibition and facilitation of the acoustic startle response: implications for pharmacological and treatment studies. J Psychopharmacol 19:39-45
2. Abel K et al (1998) Repeated testing of prepulse inhibition and habituation of the startle reflex: a study in healthy human controls. J Psychopharmacol 12:330-337
3. Abel KM et al (2003) Low dose ketamine increases prepulse inhibition in healthy men. Neuropharmacology 44:729-737
4. Adage T et al (2007) In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties. Eur Neuropsychopharmacol (in press)
5. Addington J et al (2007) North American Prodrome Longitudinal Study. North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophr Bull 33:665-672
6. Adler LE et al (1982) Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry 17:639-654
7. Afonso VM et al (2007) Medial prefrontal cortex lesions in the female rat affect sexual and maternal behavior and their sequential organization. Behav Neurosci 121:515-526
8. American Psychiatric Association (APA) (2000) Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR Fourth Edition (Text Revision)
9. Andreasen JT et al (2006) Nicotine and clozapine selectively reverse a PCP-induced deficit of PPI in BALB/cByJ but not NMRI mice: comparison with risperidone. Behav Brain Res 167:118-127
10. Auclair AL et al (2006) Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade. Neuropsychopharmacology 31:1900-1909
11. Auclair AL et al (2007) Putative antipsychotics with pronounced agonism at serotonin 5-HT1A and partial agonist activity at dopamine D2 receptors disrupt basal PPI of the startle reflex in rats. Psychopharmacology (Berl) 193:45-54
12. Bakshi VP et al (1995) A comparison of the effects of amphetamine, strychnine and caffeine on prepulse inhibition and latent inhibition. Behav Pharmacol 6:801-809
13. Ballmaier M et al (2001a) Combined alpha 2-adrenergic/D2 dopamine receptor blockade fails to reproduce the ability of clozapine to reverse phencyclidine-induced deficits in prepulse inhibition of startle. Psychopharmacology (Berl) 159:105-110
14. Ballmaier M et al (2001b) Selective immunolesioning of cholinergic neurons in nucleus basalis magnocellularis impairs prepulse inhibition of acoustic startle. Neuroscience 108:299-305
15. Ballmaier M et al (2002) Rivastigmine antagonizes deficits in prepulse inhibition induced by selective immunolesioning of cholinergic neurons in nucleus basalis magnocellularis. Neuroscience 114:91-98
16. Ballmaier M et al (2007) Cannabinoid receptor antagonists counteract sensorimotor gating deficits in the phencyclidine model of psychosis. Neuropsychopharmacology 32:2098-2107
17. Barr AM et al (2004) The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice. Neuropsychopharmacology 29:221-228
18. Barr AM et al (2006) Iloperidone reduces sensorimotor gating deficits in pharmacological models, but not a developmental model, of disrupted prepulse inhibition in rats. Neuropharmacology 51:457-465
19. Barr AM et al (2007) The reelin receptors VLDLR and ApoER2 regulate sensorimotor gating in mice. Neuropharmacology 52:1114-1123
20. Barrett SL et al (2005) Normal levels of prepulse inhibition in the euthymic phase of bipolar disorder. Psychol Med 35:1737-1746
21. Bast T et al (2001) Hyperactivity and disruption of prepulse inhibition induced by N-methyl-d-aspartate stimulation of the ventral hippocampus and the effects of pretreatment with haloperidol and clozapine. Neuroscience 103:325-335
22. Beglopoulos V et al (2005) Neurexophilin 3 is highly localized in cortical and cerebellar regions and is functionally important for sensorimotor gating and motor coordination. Mol Cell Biol 25:7278-7288
23. Bell RL et al (2003) Amphetamine-modified acoustic startle responding and prepulse inhibition in adult and adolescent alcohol-preferring and -nonpreferring rats. Pharmacol Biochem Behav 75:163-171
24. Bickel S et al (2008) Early auditory sensory processing deficits in mouse mutants with reduced NMDA receptor function. Neuropsychopharmacology (in press)
25. Bitsios P et al (2005) The effects of dopamine agonists on prepulse inhibition in healthy men depend on baseline PPI values. Psychopharmacology (Berl) 182:144-152
26. Bitsios P et al (2006) Increased prepulse inhibition of the acoustic startle response is associated with better strategy formation and execution times in healthy males. Neuropsychologia 44:2494-2499
27. Bleuler E (1911/1950) Dementia praecox; or, the group of schizophrenias. International Universities Press, New York
28. Boeckler F et al (2004) FAUC 213, a highly selective dopamine D4 receptor full antagonist, exhibits atypical antipsychotic properties in behavioural and neurochemical models of schizophrenia. Psychopharmacology (Berl) 175:7-17
29. Bontekoe CJ et al (2002) Knockout mouse model for Fxr2: a model for mental retardation. Hum Mol Genet 11:487-498
30. Borrell J et al (2002) Prenatal immune challenge disrupts sensorimotor gating in adult rats. Implications for the etiopathogenesis of schizophrenia. Neuropsychopharmacology 26:204-215
31. Bortolato M et al (2004) Baclofen reverses the reduction in prepulse inhibition of the acoustic startle response induced by dizocilpine, but not by apomorphine. Psychopharmacology (Berl) 171:322-330
32. Bortolato M et al (2005) Kappa opioid receptor activation disrupts prepulse inhibition of the acoustic startle in rats. Biol Psychiatry 57:1550-1558
33. Bortolato M et al (2006) Anxiolytic-like properties of the anandamide transport inhibitor AM404. Neuropsychopharmacology 31:2652-2659
34. Bortolato M et al (2007) Activation of GABA(B) receptors reverses spontaneous gating deficits in juvenile DBA/2J mice. Psychopharmacology (Berl) 194:361-369
35. Boucher AA et al (2007) Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Delta9-tetrahydrocannabinol. Psychopharmacology (Berl) 192:325-336
36. Bowers BJ et al (2005) Deletion of the alpha7 nicotinic receptor subunit gene results in increased sensitivity to several behavioral effects produced by alcohol. Alcohol Clin Exp Res 29:295-302
37. Boyce-Rustay JM, Holmes A (2006) Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice. Neuropsychopharmacology 31:2405-2414
38. Braff DL, Light GA (2004) Preattentional and attentional cognitive deficits as targets for treating schizophrenia. Psychopharmacology (Berl) 174:75-85
39. Braff D et al (1978) Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15:339-343
40. Braff DL et al (1992) Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry 49:206-215
41. Braff DL et al (2001a) Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophr Res 49:171-178
42. Braff DL et al (2001b) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 156:234-258
43. Braff DL et al (2005) Female schizophrenia patients have prepulse inhibition deficits. Biol Psychiatry 57:817-820
44. Braff DL et al (2007a) Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. Schizophr Bull 33:21-32
45. Braff DL et al (2007b) Prepulse Inhibition and P50 Suppression are both deficient but not correlated in schizophrenia patients. Biol Psychiatry 61:1204-1207
46. Braff et al (2008) One-year longitudinal study of 200 schizophrenia patients: no clinical, cognitive, neurophysiological or functional differences at intake in retested vs. non-retested patients. Abstr Society for Neuroscience (in press)
47. Brea J et al (2006) QF2004B, a potential antipsychotic butyrophenone derivative with similar pharmacological properties to clozapine. Neuropharmacology 51:251-262
48. Brody SA, Geyer MA (2004b) Interactions of the mGluR5 gene with breeding and maternal factors on startle and prepulse inhibition in mice. Neurotox Res 6:79-90
49. Brody SA et al (2003a) Disruption of prepulse inhibition in mice lacking mGluR1. Eur J Neurosci 18:3361-3366
50. Brody SA et al (2003b) Lamotrigine prevents ketamine but not amphetamine-induced deficits in prepulse inhibition in mice. Psychopharmacology (Berl) 169:240-246
51. Brody SA et al (2004a) Effect of antipsychotic treatment on the prepulse inhibition deficit of mGluR5 knockout mice. Psychopharmacology (Berl) 172:187-195
52. Brody SA et al (2005) A developmental influence of the N-methyl-d-aspartate receptor NR3A subunit on prepulse inhibition of startle. Biol Psychiatry 57:1147-1152
53. Browman KE et al (2004) Enhancement of prepulse inhibition of startle in mice by the H3 receptor antagonists thioperamide and ciproxifan. Behav Brain Res 153:69-76
54. Brunskill EW et al (2005) Abnormal neurodevelopment, neurosignaling and behaviour in Npas3-deficient mice. Eur J Neurosci 22:1265-1276
55. Bubenikova V et al (2005) The effect of zotepine, risperidone, clozapine and olanzapine on MK-801-disrupted sensorimotor gating. Pharmacol Biochem Behav 80:591-596
56. Burne TH et al (2004) Combined prenatal and chronic postnatal vitamin D deficiency in rats impairs prepulse inhibition of acoustic startle. Physiol Behav 81:651-655
57. Burne TH et al (2005) Behavioural characterization of vitamin D receptor knockout mice. Behav Brain Res 157:299-308
58. Burton C et al (2006) Early adversity alters attention and locomotion in adult Sprague-Dawley rats. Behav Neurosci 120:665-675
59. Butler RW, Jenkins MA, Geyer MA, Braff D (1991) Wisconsin card sorting deficits and diminished sensorimotor gating in a discrete subgroup of schizophrenic patients. In: Tamminga CA, Schulz SC (eds) Advances in neuropsychiatry and psychopharmacology. New York, NY: Raven Press, pp 163-168
60. Byrnes EM et al (2007) Sensorimotor gating and dopamine function in postpartum rats. Neuropsychopharmacology 32:1021-1031
61. Caceda R et al (2005) Virally mediated increased neurotensin 1 receptor in the nucleus accumbens decreases behavioral effects of mesolimbic system activation. J Neurosci 25:11748-11756
62. Cadenhead KS (2002) Vulnerability markers in the schizophrenia spectrum: implications for phenomenology, genetics, and the identification of the schizophrenia prodrome. Psychiatr Clin North Am 25:837-853
63. Cadenhead KS et al (1999) Prepulse inhibition and habituation of the startle response are stable neurobiological measures in a normal male population. Biol Psychiatry 45:360-364
64. Cadenhead KS et al (2002) Neurobiological measures of schizotypal personality disorder: defining an inhibitory endophenotype. Am J Psychiatry 159:869-871
65. Caine SB et al (2001) Behavioral effects of psychomotor stimulants in rats with dorsal or ventral subiculum lesions: locomotion, cocaine self-administration, and prepulse inhibition of startle. Behav Neurosci 115:880-894
66. Calkins ME et al (2004) Antisaccade performance is impaired in medically and psychiatrically healthy biological relatives of schizophrenia patients. Schizophr Res 71:167-178
67. Calkins ME et al (2007) The consortium on the genetics of endophenotypes in schizophrenia: model recruitment, assessment, and endophenotyping methods for a multi-site collaboration. Schiz Bull 33:33-48
68. Cannon TD et al (2008) Prediction of psychosis in youth at high clinical risk: a multi-site longitudinal study in North America. Arch Gen Psychiatry 65:28-37
69. Cao BJ, Li Y (2002) Reduced anxiety- and depression-like behaviors in Emx1 homozygous mutant mice. Brain Res 937:32-40
70. Carroll CA et al (2007) Sensorimotor gating in manic and mixed episode bipolar disorder. Bipolar Disord 9:221-229
71. Carter RJ et al (1999) Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J Neurosci 19:3248-3257
72. Castellanos FX et al (1996) Sensorimotor gating in boys with Tourette's syndrome and ADHD: preliminary results. Biol Psychiatry 39:33-41
73. Catapano LA, Manji HK (2007) G protein-coupled receptors in major psychiatric disorders. Biochim Biophys Acta 1768:976-993
74. Chen L, Toth M (2001) Fragile X mice develop sensory hyperreactivity to auditory stimuli. Neuroscience 103:1043-1050
75. Chiu CS et al (2005) GABA transporter deficiency causes tremor, ataxia, nervousness, and increased GABA-induced tonic conductance in cerebellum. J Neurosci 25:3234-3245
76. Choy KH, van den Buuse M (2007) Attenuated disruption of prepulse inhibition by dopaminergic stimulation after maternal deprivation and adolescent corticosterone treatment in rats. Eur Neuropsychopharmacol 18:1-13
77. Cilia J et al (2005) Reversal of isolation-rearing-induced PPI deficits by an alpha7 nicotinic receptor agonist. Psychopharmacology (Berl) 182:214-219
78. Cilia J et al (2007) (+/-) Ketamine-induced prepulse inhibition deficits of an acoustic startle response in rats are not reversed by antipsychotics. J Psychopharmacol 21:302-311
79. Clapcote SJ et al (2007) Behavioral phenotypes of Disc1 missense mutations in mice. Neuron 54:387-402
80. Conti LH et al (2005) Effects of a typical and an atypical antipsychotic on the disruption of prepulse inhibition caused by corticotropin-releasing factor and by rat strain. Behav Neurosci 119:1052-1060
81. Csomor PA et al (2008) Haloperidol differentially modulates prepulse inhibition and P50 suppression in healthy humans stratified for low and high gating levels. Neuropsychopharmacology 33:497-512
82. Cui C et al (2003) The beta3 nicotinic receptor subunit: a component of alpha-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors. J Neurosci 23:11045-11053
83. Culm KE et al (2003) Reduced G(i) and G(o) protein function in the rat nucleus accumbens attenuates sensorimotor gating deficits. Brain Res 982:12-18
84. Culm KE et al (2004) Repeated quinpirole treatment increases cAMP-dependent protein kinase activity and CREB phosphorylation in nucleus accumbens and reverses quinpirole-induced sensorimotor gating deficits in rats. Neuropsychopharmacology 29:1823-1830
85. Czyrak A et al (2003) 8-OHDPAT-induced disruption of prepulse inhibition in rats is attenuated by prolonged corticosterone treatment. Neuropsychopharmacology 28:1300-1310
86. Daenen EW et al (2003) Neonatal lesions in the amygdala or ventral hippocampus disrupt prepulse inhibition of the acoustic startle response; implications for an animal model of neurodevelopmental disorders like schizophrenia. Eur Neuropsychopharmacol 13:187-197
87. Dai H et al (2004) Social isolation stress significantly enhanced the disruption of prepulse inhibition in mice repeatedly treated with methamphetamine. Ann NY Acad Sci 1025:257-266
88. Dai H et al (2005) Blockage of histamine H1 receptor attenuates social isolation-induced disruption of prepulse inhibition: a study in H1 receptor gene knockout mice. Psychopharmacology (Berl) 183:285-293
89. Davis M (1984) The mammalian startle response. In: Eaton RC (ed) Neural mechanisms of startle behavior. Plenum Press, New York, pp 287-342
90. Davis M et al (1982) A primary acoustic startle circuit: lesion and stimulation studies. J Neurosci 2:791-805
91. Day-Wilson KM et al (2006) Medial prefrontal cortex volume loss in rats with isolation rearing-induced deficits in prepulse inhibition of acoustic startle. Neuroscience 141:1113-1121
92. de Jong IE, van den Buuse M (2006) SCH 23390 in the prefrontal cortex enhances the effect of apomorphine on prepulse inhibition of rats. Neuropharmacology 51:438-446
93. Depoortere R et al (2005) Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic. Neuropsychopharmacology 30:1963-1985
94. Depoortere R et al (2007a) F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. III. Activity in models of cognition and negative symptoms. Br J Pharmacol 151:266-277
95. Depoortere R et al (2007b) F15063, a compound with D(2)/D(3) antagonist, 5-HT(1A) agonist and D(4) partial agonist properties: (II) Activity in models of positive symptoms of schizophrenia. Br J Pharmacol 151:253-265
96. Diederich K, Koch M (2005) Role of the pedunculopontine tegmental nucleus in sensorimotor gating and reward-related behavior in rats. Psychopharmacology 179:402-408
97. Dirks A et al (2002) Reduced startle reactivity and plasticity in transgenic mice overexpressing corticotrophin-releasing hormone. Biol Psychiatry 51:583-590
98. Dirks A et al (2003) Reversal of startle gating deficits in transgenic mice overexpressing corticotrophin-releasing factor by antipsychotic drugs. Neuropsychopharmacology 28:1790-1708
99. Dolder CR et al (2002) Antipsychotic medication adherence: is there a difference between typical and atypical agents. Am J Psychiatry 159:103-108
100. Duncan EJ et al (2001) Clinical and sensorimotor gating effects of ketamin in normals. Neuropsychopharmacology 25:72-83
101. Duncan E et al (2003a) Prepulse inhibition of acoustic startle in subjects with schizophrenia treated with olanzapine or haloperidol. Psychiatry Res 120:1-12
102. Duncan EJ et al (2003b) Effect of treatment status on prepulse inhibition of acoustic startle in schizophrenia. Psychopharmacology (Berl) 167:63-71
103. Duncan GE et al (2004) Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function. Behav Brain Res 153:507-519
104. Duncan EJ et al (2006a) Medication status affects the relationship of symptoms to prepulse inhibition of acoustic startle in schizophrenia. Psychiatry Res 145:137-145
105. Duncan GE et al (2006b) Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction. Pharmacol Biochem Behav 85:481-491
106. Eells JB et al (2006) Early postnatal isolation reduces dopamine levels, elevates dopamine turnover and specifically disrupts prepulse inhibition in Nurr1-null heterozygous mice. Neuroscience 140:1117-1126
107. Egashira N et al (2005) Disruption of the prepulse inhibition of the startle reflex in vasopressin V1b receptor knockout mice: reversal by antipsychotic drugs. Neuropsychopharmacology 30:1996-2005
108. Ehlers CL et al (2007) Increased alcohol drinking in isolate-housed alcohol-preferring rats. Behav Neurosci 121:111-119
109. Ellenbroek BA, Cools AR (2002) Early maternal deprivation and prepulse inhibition: the role of the postdeprivation environment. Pharmacol Biochem Behav 73:177-184
110. Ellenbroek BA et al (1996) Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex. Neuroscience 75:535-542
111. Ellenbroek BA et al (2001) Effects of JL13, a pyridobenzoxazepine with potential atypical antipsychotic activity, in animal models for schizophrenia. J Pharmacol Exp Ther 298:386-391
112. Ellenbroek BA et al (2002b) The role of hippocampal dopamine receptors in prepulse inhibition. Eur J Neurosci 15:1237-1243
113. Elmer GI et al (2004) Altered prepulse inhibition in rats treated prenatally with the antimitotic Ara-C: an animal model for sensorimotor gating deficits in schizophrenia. Psychopharmacology (Berl) 174:177-189
114. Erbel-Sieler C et al (2004) Behavioral and regulatory abnormalities in mice deficient in the NPAS1 and NPAS3 transcription factors. Proc Natl Acad Sci USA 101:13648-13653
115. Erhardt S et al (2004) Endogenous kynurenic acid disrupts prepulse inhibition. Biol Psychiatry 56:255-260
116. Ewers M et al (2006) Associative and motor learning in 12-month-old transgenic APP+PS1 mice. Neurobiol Aging 27:1118-1128
117. Feifel D, Priebe K (2001) Vasopressin-deficient rats exhibit sensorimotor gating deficits that are reversed by subchronic haloperidol. Biol Psychiatry 50:425-433
118. Feifel D et al (2001) Startle and sensorimotor gating in rats lacking CCK-A receptors. Neuropsychopharmacology 24:663-670
119. Feifel D et al (2004) Reversal of sensorimotor gating deficits in Brattleboro rats by acute administration of clozapine and a neurotensin agonist, but not haloperidol: a potential predictive model for novel antipsychotic effects. Neuropsychopharmacology 29:731-738
120. Fejgin K et al (2007) The atypical antipsychotic, aripiprazole, blocks phencyclidine-induced disruption of prepulse inhibition in mice. Psychopharmacology (Berl) 191:377-385
121. Ferguson SA, Cada AM (2004) Spatial learning/memory and social and nonsocial behaviors in the spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley rat strains. Pharmacol Biochem Behav 77:583-594
122. Finamore TL et al (2001) Contributions of hippocampal cellular damage and NMDA receptor dysfunction to behavioral markers of schizophrenia. Int J Neurosci 109:61-70
123. Fitting S et al (2006a) Intrahippocampal injections of Tat: effects on prepulse inhibition of the auditory startle response in adult male rats. Pharmacol Biochem Behav 84:189-196
124. Fitting S et al (2006b) Neonatal hippocampal Tat injections: developmental effects on prepulse inhibition (PPI) of the auditory startle response. Int J Dev Neurosci 24:275-283
125. Fitting S et al (2006c) Neonatal intrahippocampal glycoprotein 120 injection: the role of dopaminergic alterations in prepulse inhibition in adult rats. J Pharmacol Exp Ther 318:1352-1358
126. Flaten MA (2002) Test-retest reliability of the somatosensory blink reflex and its inhibition. Int J Psychophysiol 45:261-265
127. Flood DG et al (2008) Variables affecting prepulse inhibition of the startle reflex and the response to antipsychotics in DBA/2NCrl mice. Psychopharmacology (Berl) 195:203-211
128. Fortier ME et al (2007) Effects of prenatal infection on prepulse inhibition in the rat depend on the nature of the infectious agent and the stage of pregnancy. Behav Brain Res 181:270-277
129. Fox GB et al (2005) Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist. J Pharmacol Exp Ther 313:176-190
130. Fradley RL et al (2005) STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating. Behav Brain Res 163:257-264
131. Frankland PW et al (2004) Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice. Mol Psychiatry 9:417-425
132. Frau R et al (2007) Effects of topiramate on the prepulse inhibition of the acoustic startle in rats. Neuropsychopharmacology 32:320-331
133. Freedman R et al (1997) Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA 94:587-592
134. Freudenberg F et al (2007) Selective breeding for deficient sensorimotor gating is accompanied by increased perseveration in rats. Neuroscience 148:612-622
135. Fujiwara N et al (2006) Effects of copper metabolism on neurological functions in Wistar and Wilson's disease model rats. Biochem Biophys Res Commun 349:1079-1086
136. Futamura T et al (2003) Neonatal perturbation of neurotrophic signaling results in abnormal sensorimotor gating and social interaction in adults: implication for epidermal growth factor in cognitive development. Mol Psychiatry 8:19-29
137. Galici R et al (2005) A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity. J Pharmacol Exp Ther 315:1181-1187
138. Garner B et al (2007) Early maternal deprivation reduces prepulse inhibition and impairs spatial learning ability in adulthood: no further effect of post-pubertal chronic corticosterone treatment. Behav Brain Res 176:323-332
139. George TP et al (2006) A preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: involvement of nicotinic receptor mechanisms. Schizophr Res 87:307-315
140. Geyer MA, Swerdlow NR (1998) Measurement of startle response, prepulse inhibition, and habituation. In: Crawley JN, Skolnick P (eds) Current protocols in neuroscience, Unit 8.7. Wiley, New York, pp 1-15
141. Geyer MA et al (1993) Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia. Biol Psychiatry 34:361-372
142. Geyer MA et al (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156:117-154
143. Geyer MA et al (2002) Mouse genetic models for prepulse inhibition: an early review. Mol Psychiatry 7:1039-1053
144. Gizerian SS et al (2006) Neonatal neurosteroid administration results in development-specific alterations in prepulse inhibition and locomotor activity: neurosteroids alter prepulse inhibition and locomotor activity. Psychopharmacology (Berl) 186:334-342
145. Gogos A, Van den Buuse M (2004) Estrogen and progesterone prevent disruption of prepulse inhibition by the serotonin-1A receptor agonist 8-hydroxy-2-dipropylaminotetralin. J Pharmacol Exp Ther 309:267-274
146. Gogos A et al (2006) Oestrogen modulation of the effect of 8-OH-DPAT on prepulse inhibition: effects of aromatase deficiency and castration in mice. Psychopharmacology (Berl) 188:100-110
147. Gomez-Wong E et al (1998) Sensory modulation of the blink reflex in patients with blepharospasm. Arch Neurol 55:1233-1237
148. Goto K et al (2002) Reduced prepulse inhibition in rats with entorhinal cortex lesions. Behav Brain Res 134:201-207
149. Goto K et al (2004) Involvement of nucleus accumbens dopaminergic transmission in acoustic startle: observations concerning prepulse inhibition in rats with entorhinal cortex lesions. Psychiatry Clin Neurosci 58:441-445
150. Gottesman II, Gould TD (2003) The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160:636-645
151. Gould TD, Gottesman II (2006) Psychiatric endophenotypes and the development of valid animal models. Genes Brain Behav 5:113-119
152. Gould TJ et al (2004) Sensorimotor gating deficits in transgenic mice expressing a constitutively active form of Gs alpha. Neuropsychopharmacology 29:494-501
153. Graham F (1975) The more or less startling effects of weak prestimuli. Psychophysiology 12:238-248
154. Gray JA (1995) The contents of consciousness: a neuropsychological conjecture. Behav Brain Sci 18:659-722
155. Greenwood TA et al (2007) The Consortium on the Genetics of Schizophrenia (COGS): Preliminary heritability analyses of endophenotypic measures for schizophrenia. Arch Gen Psychiatry 33:33-48
156. Grillon C et al (1998) Effects of experimental context and explicit threat cues on acoustic startle in Vietnam veterans with posttraumatic stress disorder. Biol Psychiatry 44:1027-1036
157. Grobin AC et al (2006) Perinatal allopregnanolone influences prefrontal cortex structure, connectivity and behavior in adult rats. Neuroscience 138:809-819
158. Grobstein P (2005) Making the unconscious conscious: a bi-directional bridge between neuroscience/ cognitive science and psychotherapy. Cortex 41:663-668
159. Groenink L et al (2008) CRF(1) not glucocorticoid receptors mediate prepulse inhibition deficits in mice overexpressing CRF. Biol Psychiatry 63:360-368
160. Harris LW et al (2003) Long-term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonism. Eur J Neurosci 18:1706-1710
161. Harrison SM et al (2003) LPA1 receptor-deficient mice have phenotypic changes observed in psychiatric disease. Mol Cell Neurosci 24:1170-1179
162. Harte MK et al (2007) Deficits in parvalbumin and calbindin immunoreactive cells in the hippocampus of isolation reared rats. J Neural Transm 114:893-898
163. Hauser J et al (2005) Hippocampal alpha5 subunit-containing GABAA receptors modulate the expression of prepulse inhibition. Mol Psychiatry 10:201-207
164. Hauser J et al (2006) Prenatal dexamethasone exposure, postnatal development, and adulthood prepulse inhibition and latent inhibition in Wistar rats. Behav Brain Res 175:51-61
165. Hazlett EA et al (2003) Deficient attentional modulation of the startle response in patients with schizotypal personality disorder. Am J Psychiatry 160:1621-1626
166. Heldt SA, Ressler KJ (2006) Lesions of the habenula produce stress- and dopamine-dependent alterations in prepulse inhibition and locomotion. Brain Res 1073-1074:229-239
167. Heldt SA et al (2004) Prepulse inhibition deficits in GAD65 knockout mice and the effect of antipsychotic treatment. Neuropsychopharmacology 29:1610-1619
168. Henck JW et al (2001) Growth and development in rats given recombinant human epidermal growth factor(1-48) as neonates. Toxicol Sci 62:80-91
169. Heresco-Levy U et al (2007) High glycine levels are associated with prepulse inhibition deficits in chronic schizophrenia patients. Schizophr Res 91:14-21
170. Hoenig K et al (2005) Impaired prepulse inhibition of acoustic startle in obsessive-compulsive disorder. Biol Psychiatry 57:1153-1158
171. Hohnadel E et al (2007) Galantamine and donepezil attenuate pharmacologically induced deficits in prepulse inhibition in rats. Neuropharmacology 52:542-551
172. Holmes A et al (2001) Behavioral characterization of dopamine D5 receptor null mutant mice. Behav Neurosci 115:1129-1144
173. Hong LE et al (2007) Independent domains of inhibitory gating in schizophrenia and the effect of stimulus interval. Am J Psychiatry 164:61-65
174. Howland JG et al (2004a) Delayed onset of prepulse inhibition deficits following kainic acid treatment on postnatal day 7 in rats. Eur J Neurosci 20:2639-2648
175. Howland JG et al (2004b) Electrical stimulation of the hippocampus disrupts prepulse inhibition in rats: frequency- and site-dependent effects. Behav Brain Res 152:187-197
176. Howland JG et al (2007) Kindling of basolateral amygdala but not ventral hippocampus or perirhinal cortex disrupts sensorimotor gating in rats. Behav Brain Res 177:30-36
177. Hsieh MH et al (2006) Effects of background and prepulse characteristics on prepulse inhibition and prepulse facilitation: implications for neuropsychiatric research. Biol Psychiatry 15 59(6):555-559
178. Husum H et al (2002) Early maternal deprivation alters hippocampal levels of neuropeptide Y and calcitonin-gene related peptide in adult rats. Neuropharmacology 42:798-806
179. Hutchison KE, Swift R (1999) Effect of d-amphetamine on prepulse inhibition of the startle reflex in humans. Psychopharmacology (Berl) 143:394-400
180. Inada K et al (2003) Antisense hippocampal knockdown of NMDA-NR1 by HVJ-liposome vector induces deficit of prepulse inhibition but not of spatial memory. Neurosci Res 45:473-481
181. Irintchev A et al (2004) Impairment of sensorimotor gating in mice deficient in the cell adhesion molecule L1 or its close homologue, CHL1. Brain Res 1029:131-134
182. Iso H et al (2007) Environmental change during postnatal development alters behaviour, cognitions and neurogenesis of mice. Behav Brain Res 179:90-98
183. Jaworski DM et al (2005) Prepulse inhibition and fear-potentiated startle are altered in tissue inhibitor of metalloproteinase-2 (TIMP-2) knockout mice. Brain Res 1051:81-89
184. Jones CK, Shannon HE (2004) Lesions of the laterodorsal tegmental nucleus disrupt prepulse inhibition of the acoustic startle reflex. Pharmacol Biochem Behav 78:229-237
185. Jones CK et al (2005) Pharmacologic interactions between the muscarinic
186. Jongen-Relo AL et al (2004) The prenatal methylazoxymethanol acetate treatment: a neurodevelopmental animal model for schizophrenia. Behav Brain Res 149:159-181
187. Jovanovic T et al (2004) Menstrual cycle phase effects on prepulse inhibition of acoustic startle. Psychophysiology 41:401-406
188. Kaifu T et al (2003) Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J Clin Invest 111:323-332
189. Kanabus M et al (2002) Temporal order judgement for auditory and visual stimuli. Acta Neurobiol Exp 62:263-270
190. Kanes SJ et al (2007) Rolipram: a specific phosphodiesterase 4 inhibitor with potential antipsychotic activity. Neuroscience 144:239-246
191. Karper LP et al (1996) Preliminary evidence of an association between sensorimotor gating and distractibility in psychosis. J Neuropsychiatry Clin Neurosci 8:60-66
192. Kedzior KK, Martin-Iverson MT (2007) Attention-dependent reduction in prepulse inhibition of the startle reflex in cannabis users and schizophrenia patients-a pilot study. Eur J Pharmacol 560:176-182
193. Kelly MP et al (2007) Constitutive activation of Galphas within forebrain neurons causes deficits in sensorimotor gating because of PKA-dependent decreases in cAMP. Neuropsychopharmacology 32:577-588
194. Kimura J, Harada O (1976) Recovery curves of the blink reflex during wakefulness and sleep. J Neurol 213:189-198
195. Kinkead B et al (2005) Neurotensin-deficient mice have deficits in prepulse inhibition: restoration by clozapine but not haloperidol, olanzapine, or quetiapine. J Pharmacol Exp Ther 315:256-264
196. Kinney GG et al (2003) The glycine transporter type 1 inhibitor N-[3-(4′-fluorophenyl)-3-(4′-phenylphenoxy)propyl]sarcosine potentiates NMDA receptor-mediated responses in vivo and produces an antipsychotic profile in rodent behavior. J Neurosci 23:7586-7591
197. Kinney GG et al (2005) A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models. J Pharmacol Exp Ther 313:199-206
198. Klamer D et al (2004a) Phencyclidine-induced behaviour in mice prevented by methylene blue. Basic Clin Pharmacol Toxicol 94:65-72
199. Klamer D et al (2004b) The neuronal selective nitric oxide synthase inhibitor, Nomega-propyl-l-arginine, blocks the effects of phencyclidine on prepulse inhibition and locomotor activity in mice. Eur J Pharmacol 503:103-107
200. Klamer D et al (2005a) Activation of a nitric-oxide-sensitive cAMP pathway with phencyclidine: elevated hippocampal cAMP levels are temporally associated with deficits in prepulse inhibition. Psychopharmacology (Berl) 179:479-488
201. Klamer D et al (2005b) Effects of phencyclidine on acoustic startle and prepulse inhibition in neuronal nitric oxide synthase deficient mice. Eur Neuropsychopharmacol 15:587-590
202. Klejbor I et al (2006) Fibroblast growth factor receptor signaling affects development and function of dopamine neurons-inhibition results in a schizophrenia-like syndrome in transgenic mice. J Neurochem 97:1243-1258
203. Koch M, Schnitzler HU (1997) The acoustic startle response in rats-circuits mediating evocation, inhibition and potentiation. Behav Brain Res 89:35-49
204. Koch M et al (1993) Cholinergic neurons in the pedunculopontine tegmental nucleus are involved in the mediation of prepulse inhibition of the acoustic startle response in the rat. Exp Brain Res 97:71-82
205. Koenig JI et al (2005) Prenatal exposure to a repeated variable stress paradigm elicits behavioral and neuroendocrinological changes in the adult offspring: potential relevance to schizophrenia. Behav Brain Res 156:251-261
206. Koh HY et al (2008) Deficits in social behavior and sensorimotor gating in mice lacking phospholipase Cbeta1. Genes Brain Behav 7:120-128
207. Kraepelin E, Robertson GM (1919) Dementia praecox and paraphrenia. Livingstone Edinburgh
208. Krebs-Thomson K et al (2006) The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats. Psychopharmacology (Berl) 189:319-329
209. Kumari V et al (1999) Normalization of information processing deficits in schizophrenia with clozapine. Am J Psychiatry 156:1046-1051
210. Kumari V et al (2001) Influence of cigarette smoking on prepulse inhibition of the acoustic startle response in schizophrenia. Hum Psychopharmacol 16:321-326
211. Kumari V et al (2002) Prepulse inhibition of the startle response in risperidone-treated patients: comparison with typical antipsychotics. Schizophr Res 55:139-146
212. Kumari V et al (2003a) Neural correlates of tactile prepulse inhibition: a functional MRI study in normal and schizophrenic subjects. Psychiatry Res 122:99-113
213. Kumari V et al (2003b) Effects of acute procyclidine administration on prepulse inhibition of the startle response in schizophrenia: a double-blind, placebo-controlled study. J Psychopharmacol 17:89-95
214. Kumari V et al (2004) Sex differences in prepulse inhibition deficits in chronic schizophrenia. Schizophr Res 69:219-235
215. Kumari V et al (2005a) Association between violent behaviour and impaired prepulse inhibition of the startle response in antisocial personality disorder and schizophrenia. Behav Brain Res 158:159-166
216. Kumari V et al (2005b) Lack of association between prepulse inhibition and antisaccadic deficits in chronic schizophrenia: implications for identification of schizophrenia endophenotypes. J Psychiatr Res 39:227-240
217. Kumari V et al (2005c) Structural brain correlates of prepulse inhibition of the acoustic startle response in healthy humans. Neuroimage 26:1052-1058
218. Kumari V et al (2005d) Reduced prepulse inhibition in unaffected siblings of schizophrenia patients. Psychophysiology 42:588-594
219. Kumari V et al (2007a) A fMRI investigation of startle gating deficits in schizophrenia patients treated with typical or atypical antipsychotics. Int J Neuropsychopharmacol 10:463-477
220. Kumari V et al (2007b) Startle gating in antipsychotic-naive first episode schizophrenia patients: one ear is better than two. Psychiatry Res 151:21-28
221. Kusljic S, van den Buuse M (2004) Functional dissociation between serotonergic pathways in dorsal and ventral hippocampus in psychotomimetic drug-induced locomotor hyperactivity and prepulse inhibition in rats. Eur J Neurosci 20:3424-3432
222. Kusljic S, van den Buuse M (2006) Differential involvement of 5-HT projections within the amygdala in prepulse inhibition but not in psychotomimetic drug-induced hyperlocomotion. Behav Brain Res 168:74-82
223. Kusljic S et al (2003) Differential role of serotonergic projections arising from the dorsal and median raphe nuclei in locomotor hyperactivity and prepulse inhibition. Neuropsychopharmacology 28:2138-2147
224. Kusljic S et al (2006) Effects of haloperidol and clozapine on sensorimotor gating deficits induced by 5-hydroxytryptamine depletion in the brain. Br J Pharmacol 147:800-807
225. Lacro JP et al (2002) Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 63:892-909
226. Lahdesmaki J et al (2004) Alpha2A-adrenoceptors are important modulators of the effects of d-amphetamine on startle reactivity and brain monoamines. Neuropsychopharmacology 29:1282-1293
227. Laplante F et al (2005) Alterations in behavioral responses to a cholinergic agonist in post-pubertal rats with neonatal ventral hippocampal lesions: relationship to changes in muscarinic receptor levels. Neuropsychopharmacology 30:1076-1087
228. Le Pen G, Moreau JL (2002) Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidol. Neuropsychopharmacology 27:1-11
229. Le Pen G et al (2003) Prepulse inhibition deficits of the startle reflex in neonatal ventral hippocampal-lesioned rats: reversal by glycine and a glycine transporter inhibitor. Biol Psychiatry 54:1162-1170
230. Le Pen G et al (2006) Peri-pubertal maturation after developmental disturbance: a model for psychosis onset in the rat. Neuroscience 143:395-405
231. Leppert M et al (1990) Genetic analysis of an inherited predisposition to colon cancer in a family with a variable number of adenomatous polyps. N Engl J Med 322:904-908
232. Leumann L et al (2002) Effects of typical and atypical antipsychotics on prepulse inhibition and latent inhibition in chronic schizophrenia. Biol Psychiatry 52:729-739
233. Libet B et al (1979) Subjective referral of the timing for a conscious sensory experience. Brain 102:192-224
234. Lieberman JA et al (2005) Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353:1209-1223
235. Light GA, Braff DL (2005) Mismatch negativity deficits are associated with poor functioning in schizophrenia patients. Arch Gen Psychiatry 62:127-136
236. Light GA et al (2004) Probing cortical-cortical interactions that underlie the multiple sensory, cognitive, and "real-world" functional deficits in schizophrenia. Behav Brain Sci 27:799
237. Light GA et al (2007a) One year stability of neurophysiological and cognitive endophenotypes of schizophrenia. Proc Am Col Neuropsychopharmacology (in press)
238. Light GA et al (2007b) Prepulse inhibition of startle is positively associated with higher order cognition in women. Abstr Soc Neurosciences 806.17
239. Light GA et al (2008) Preattentive sensory processing is associated with cognitive and psychosocial functioning in healthy adults. J Cog Neurosci 7:120-128
240. Ligneau X et al (2007) Brain histamine and schizophrenia: potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649. Biochem Pharmacol 73:1215-1224
241. Linn GS et al (2003) Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys. Psychopharmacology (Berl) 169:234-239
242. Lipina T et al (2005) Modulators of the glycine site on NMDA receptors, D-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia. Psychopharmacology (Berl) 179:54-67
243. Lipina T et al (2007) The ampakine CX546 restores the prepulse inhibition and latent inhibition deficits in mGluR5-deficient mice. Neuropsychopharmacology 32:745-756
244. Lipska BK et al (1995) Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology 122:35-43
245. Long LE et al (2006) Cannabidiol reverses MK-801-induced disruption of prepulse inhibition in mice. Neuropsychopharmacology 31:795-803
246. Lovic V, Fleming AS (2004) Artificially-reared female rats show reduced prepulse inhibition and deficits in the attentional set shifting task-reversal of effects with maternal-like licking stimulation. Behav Brain Res 148:209-219
247. Ludewig K, Vollenweider FX (2002) Impaired sensorimotor gating in schizophrenia with deficit and with nondeficit syndrome. Swiss Med Wkly 132:159-165
248. Ludewig K et al (2002) Stability of the acoustic startle reflex, prepulse inhibition, and habituation in schizophrenia. Schizophr Res 55:129-137
249. Ludewig K et al (2003) Deficits in prepulse inhibition and habituation in never-medicated, first-episode schizophrenia. Biol Psychiatry 54:121-128
250. Ma J, Leung LS (2004) Schizophrenia-like behavioral changes after partial hippocampal kindling. Brain Res 997:111-118
251. Ma J, Leung LS (2007) The supramammillo-septal-hippocampal pathway mediates sensorimotor gating impairment and hyperlocomotion induced by MK-801 and ketamine in rats. Psychopharmacology (Berl) 191:961-974
252. Ma J et al (2004) The medial septum mediates impairment of prepulse inhibition of acoustic startle induced by a hippocampal seizure or phencyclidine. Behav Brain Res 155:153-166
253. Mackeprang T et al (2002) Effects of antipsychotics on prepulse inhibition of the startle response in drug-naive schizophrenic patients. Biol Psychiatry 52:863-873
254. Malone DT et al (2004) The effect of SR 141716 and apomorphine on sensorimotor gating in Swiss mice. Pharmacol Biochem Behav 77:839-845
255. Mansbach RS, Geyer MA (1989) Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacology 2:299-308
256. Mansbach RS et al (1988) Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology (Berl) 94:507-514
257. Marquis KL et al (2007) WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a- octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: a novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity. J Pharmacol Exp Ther 320:486-496
258. McCool MF et al (2003) Increased auditory startle response and reduced prepulse inhibition of startle in transgenic mice expressing a double mutant form of amyloid precursor protein. Brain Res 994:99-106
259. McDonald MP et al (2001) Motor deficits in fibroblast growth factor receptor-3 null mutant mice. Behav Pharmacol 12:477-486
260. McGhie A, Chapman J (1961) Disorders of attention and perception in early schizophrenia. Brit J Med Psychol 34:103-116
261. Meincke U et al (2004) Prepulse inhibition of the acoustically evoked startle reflex in patients with an acute schizophrenic psychosis-a longitudinal study. Eur Arch Psychiatry Clin Neurosci 254:415-421
262. Metzger KL et al (2007) Pharmacokinetic and behavioral characterization of a long-term antipsychotic delivery system in rodents and rabbits. Psychopharmacology (Berl) 190:201-211
263. Minassian A et al (2007) The relationship between sensorimotor gating and clinical improvement in acutely ill schizophrenia patients. Schizophr Res 89:225-231
264. Miyakawa T et al (2003) Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc Natl Acad Sci USA 100:8987-8992
265. Mohr D et al (2007) Accumbal dopamine D2 receptors are important for sensorimotor gating in C3H mice. Neuroreport 18:1493-1497
266. Moy SS et al (2006) Amphetamine-induced disruption of prepulse inhibition in mice with reduced NMDA receptor function. Brain Res 1089:186-194
267. Mukai J et al (2004) Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia. Nat Genet 36:725-731
268. Murphy CA et al (2001) Latent inhibition, but not prepulse inhibition, is reduced during withdrawal from an escalating dosage schedule of amphetamine. Behav Neurosci 115:1247-1256
269. Myers KM et al (2005) Partial reversal of phencyclidine-induced impairment of prepulse inhibition by secretin. Biol Psychiatry 58:67-73
270. Nagai H et al (2006) Antipsychotics improve Delta9-tetrahydrocannabinol- induced impairment of the prepulse inhibition of the startle reflex in mice. Pharmacol Biochem Behav 84:330-336
271. Nagel J et al (2003) Effects of an adenosine A2A receptor blockade in the nucleus accumbens on locomotion, feeding, and prepulse inhibition in rats. Synapse 49:279-286
272. Nunes Mamede Rosa ML et al (2005) Isolation-induced changes in ultrasonic vocalization, fear-potentiated startle and prepulse inhibition in rats. Neuropsychobiology 51:248-255
273. Nyffeler M et al (2006) Maternal immune activation during pregnancy increases limbic GABAA receptor immunoreactivity in the adult offspring: implications for schizophrenia. Neuroscience 143:51-62
274. Ojima T et al (2004) Effects of serotonin-dopamine antagonists on prepulse inhibition and neurotransmitter contents in the rat cortex. Neurosci Lett 366:130-134
275. Ong JC et al (2005) An investigation of the efficacy of mood stabilizers in rodent models of prepulse inhibition. J Pharmacol Exp Ther 315:1163-1171
276. Oranje B et al (2002) Effects of typical and atypical antipsychotics on the prepulse inhibition of the startle reflex in patients with schizophrenia. J Clin Psychopharmacol 22:359-365
277. Ouagazzal AM et al (2001a) Drug-induced potentiation of prepulse inhibition of acoustic startle reflex in mice: a model for detecting antipsychotic activity. Psychopharmacology (Berl) 156:273-283
278. Ouagazzal AM et al (2001b) Effect of LSD on prepulse inhibition and spontaneous behavior in the rat. a pharmacological analysis and comparison between two rat strains. Neuropsychopharmacology 25:565-575
279. Ozawa K et al (2006) Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol Psychiatry 59:546-554
280. Paine TA et al (2007) Sensitivity of the five-choice serial reaction time task to the effects of various psychotropic drugs in Sprague-Dawley rats. Biol Psychiatry 62:687-693
281. Palmer AA et al (2000) Prepulse startle deficit in the Brown Norway rat: a potential genetic model. Behav Neurosci 114:374-388
282. Palmer AA et al (2004) Prenatal protein deprivation in rats induces changes in prepulse inhibition and NMDA receptor binding. Brain Res 996:193-201
283. Palsson E et al (2007) The amino acid l-lysine blocks the disruptive effect of phencyclidine on prepulse inhibition in mice. Psychopharmacology (Berl) 192:9-15
284. Park C et al (2002) Deletion in Catna2, encoding alpha N-catenin, causes cerebellar and hippocampal lamination defects and impaired startle modulation. Nat Genet 31:279-284
285. Park WK et al (2005) KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia. Pharmacol Biochem Behav 82:361-372
286. Paylor R et al (2006) Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc Natl Acad Sci USA 103:7729-7734
287. Peak H (1939) Time order error in successive judgements and in reflexes. I. Inhibition of the judgement and the reflex. J Exper Psychol 25:535-565
288. Peleg-Raibstein D et al (2006a) Differential effects on prepulse inhibition of withdrawal from two different repeated administration schedules of amphetamine. Int J Neuropsychopharmacol 9:737-749
289. Peleg-Raibstein D et al (2006b) Withdrawal from repeated amphetamine administration leads to disruption of prepulse inhibition but not to disruption of latent inhibition. J Neural Transm 113:1323-1336
290. Perry W, Braff DL (1994) Information-processing deficits and thought disorder in schizophrenia. Am J Psychiatry 151:363-367
291. Perry W et al (2001) Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania. Biol Psychiatry 50418-424
292. Perry W et al (2002) Information processing deficits in acutely psychotic schizophrenia patients medicated and unmedicated at the time of admission. Am J Psychiatry 159:1375-1381
293. Perry W et al (2004) Prepulse inhibition in patients with non-psychotic major depressive disorder. J Affect Disord 81:179-184
294. Petitto JM et al (2002a) IL-2/15 receptor-beta gene deletion alters neurobehavioral performance. Brain Res 929:218-225
295. Petitto JM et al (2002b) Relationship between the development of autoimmunity and sensorimotor gating in MRL-lpr mice with reduced IL-2 production. Neurosci Lett 328:304-308
296. Pijlman FT et al (2003) Behavioural changes after different stress paradigms: prepulse inhibition increased after physical, but not emotional stress. Eur Neuropsychopharmacol 13:369-380
297. Pillai-Nair N et al (2005) Neural cell adhesion molecule-secreting transgenic mice display abnormalities in GABAergic interneurons and alterations in behavior. J Neurosci 25:4659-4671
298. Pletnikov MV et al (2002) Effects of genetic background on neonatal Borna disease virus infection-induced neurodevelopmental damage. I. Brain pathology and behavioral deficits. Brain Res 944:97-107
299. Podhorna J, Didriksen M (2004) The heterozygous reeler mouse: behavioural phenotype. Behav Brain Res 153:43-54
300. Porras-Garcia E et al (2005) Purkinje cell loss affects differentially the execution, acquisition and prepulse inhibition of skeletal and facial motor responses in Lurcher mice. Eur J Neurosci 21:979-988
301. Postma P et al (2006) A behavioural and functional neuroimaging investigation into the effects of nicotine on sensorimotor gating in healthy subjects and persons with schizophrenia. Psychopharmacology 184:589-599
302. Pothuizen HH et al (2005) The effects of temporary inactivation of the core and the shell subregions of the nucleus accumbens on prepulse inhibition of the acoustic startle reflex and activity in rats. Neuropsychopharmacology 30:683-696
303. Pothuizen HH, Neumann KR, Feldon J, Yee BK (2006) Selective nucleus accumbens core lesions enhance dizocilpine-induced but not apomorphine-induced disruption of prepulse inhibition in rats. Behav Pharmacol 17:107-117
304. Pouzet B et al (2002a) Effects of the 5-HT(6) receptor antagonist, SB-271046, in animal models for schizophrenia. Pharmacol Biochem Behav 71:635-643
305. Pouzet B et al (2002b) Effects of the 5-HT(7) receptor antagonist SB-258741 in animal models for schizophrenia. Pharmacol Biochem Behav 71:655-665
306. Powell KJ et al (2006) Neonatal ventral hippocampal lesions produce an elevation of DeltaFosB-like protein(s) in the rodent neocortex. Neuropsychopharmacology 31:700-711
307. Powell SB et al (2002) Isolation rearing-induced deficits in prepulse inhibition and locomotor habituation are not potentiated by water deprivation. Physiol Behav 77:55-64
308. Powell SB et al (2003) Dopamine depletion of the nucleus accumbens reverses isolation-induced deficits in prepulse inhibition in rats. Neuroscience 119:233-240
309. Powell SB et al (2006a) Antipsychotic prophylaxis: initial studies on prepulse inhibition and weight gain with sustained clozapine treatment. Society for Neuroscience Atlanta, GA, Program No. 587.12
310. Powell SB et al (2006b) Startle gating deficits after isolation rearing: strain differences and effects of sustained clozapine treatment. Biol Psychiatry 59:221S
311. Quednow BB et al (2006) Sensorimotor gating and habituation of the startle response in schizophrenic patients randomly treated with amisulpride or olanzapine. Biol Psychiatry 59:536-545
312. Radant AD et al (2007) Successful multi-site measurement of antisaccade performance deficits in schizophrenia. Schizophr Res 89:320-329
313. Rajakumar N et al (2004) Altered neurotrophin receptor function in the developing prefrontal cortex leads to adult-onset dopaminergic hyperresponsivity and impaired prepulse inhibition of acoustic startle. Biol Psychiatry 55:797-803
314. Ralph RJ, Caine SB (2005) Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice. J Pharmacol Exp Ther 312:733-741
315. Ralph RJ, Caine SB (2007) Effects of selective dopamine D1-like and D2-like agonists on prepulse inhibition of startle in inbred C3H/HeJ, SPRET/EiJ, and CAST/EiJ mice. Psychopharmacology (Berl) 191:731-739
316. Ralph RJ et al (1999) The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice. J Neurosci 19:4627-4633
317. Ralph-Williams RJ et al (2002) Differential effects of direct and indirect dopamine agonists on prepulse inhibition: a study in D1 and D2 receptor knock-out mice. J Neurosci 22:9604-9611
318. Ralph-Williams RJ et al (2003a) Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice. Neuropsychopharmacology 28:108-118
319. Ralph-Williams RJ et al (2003b) Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system. Biol Psychiatry 53:352-359
320. Rasmussen BA et al (2007) Long-term effects of developmental PCP administration on sensorimotor gating in male and female rats. Psychopharmacology (Berl) 190:43-49
321. Razoux F et al (2007) Ketamine, at a dose that disrupts motor behavior and latent inhibition, enhances prefrontal cortex synaptic efficacy and glutamate release in the nucleus accumbens. Neuropsychopharmacology 32:719-727
322. Rehn AE et al (2004) An animal model of chronic placental insufficiency: relevance to neurodevelopmental disorders including schizophrenia. Neuroscience 129:381-391
323. Rich BA et al (2005) An investigation of prepulse inhibition in pediatric bipolar disorder. Bipolar Disord 7:198-203
324. Risbrough VB et al (2004) Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior. J Neurosci 24:6545-6552
325. Risterrucci C et al (2005) Functional magnetic resonance imaging reveals similar brain activity changes in two different animal models of schizophrenia. Psychopharmacology 180:724-734
326. Roegge CS et al (2007) Histamine H1 receptor involvement in prepulse inhibition and memory function: relevance for the antipsychotic actions of clozapine. Pharmacol Biochem Behav 86:686-692
327. Romero E et al (2007) Neurobehavioral and immunological consequences of prenatal immune activation in rats. Influence of antipsychotics. Neuropsychopharmacology 32:1791-1804
328. Rosa ML et al (2005) Routine post-weaning handling of rats prevents isolation rearing-induced deficit in prepulse inhibition. Braz J Med Biol Res 38:1691-1696
329. Roy MA et al (1997) Selecting a control group in studies of the familial coaggregation of two disorders: a quantitative genetics perspective. Am J Med Genet 74:296-303
330. Rueter LE et al (2004) Chronic low dose risperidone and clozapine alleviate positive but not negative symptoms in the rat neonatal ventral hippocampal lesion model of schizophrenia. Psychopharmacology (Berl) 176:312-319
331. Russig H et al (2004) Apomorphine-induced disruption of prepulse inhibition that can be normalised by systemic haloperidol is insensitive to clozapine pretreatment. Psychopharmacology (Berl) 175:143-147
332. Sakaue M et al (2003) The 5-HT1A receptor agonist MKC-242 reverses isolation rearing-induced deficits of prepulse inhibition in mice. Psychopharmacology (Berl) 170:73-79
333. Sallinen J et al (2007) Pharmacological characterization and CNS effects of a novel highly selective alpha2C-adrenoceptor antagonist JP-1302. Br J Pharmacol 150:391-402
334. Salum C et al (2006) Dopamine and nitric oxide interaction on the modulation of prepulse inhibition of the acoustic startle response in the Wistar rat. Psychopharmacology (Berl) 185:133-141
335. Sandager-Nielsen K et al (2004) Effects of postnatal anoxia on striatal dopamine metabolism and prepulse inhibition in rats. Pharmacol Biochem Behav 77:767-774
336. Sandner G et al (2002) Effects of ketamine and apomorphine on inferior colliculus and caudal pontine reticular nucleus evoked potentials during prepulse inhibition of the startle reflex in rats. Behav Brain Res 128:161-168
337. Schmitt A et al (2007) Altered NMDA receptor expression and behavior following postnatal hypoxia: potential relevance to schizophrenia. J Neural Transm 114:239-248
338. Schneider M, Koch M (2003) Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats. Neuropsychopharmacology 28:1760-1769
339. Schneider M, Koch M (2005) Behavioral and morphological alterations following neonatal excitotoxic lesions of the medial prefrontal cortex in rats. Exp Neurology 195:185-198
340. Schneider M et al (2005) Behavioral effects in adult rats of chronic prepubertal treatment with the cannabinoid receptor agonist WIN 55,212-2. Behav Pharmacol 16:447-454
341. Schneider T et al (2006) Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: issues for a therapeutic approach in autism. Neuropsychopharmacology 31:36-46
342. Schwabe K, Koch M (2004) Role of the medial prefrontal cortex in N-methyl-d-aspartate receptor antagonist induced sensorimotor gating deficit in rats. Neurosci Lett 355:5-8
343. Schwabe K et al (2004) Effects of neonatal lesions of the medial prefrontal cortex on adult rat behaviour. Behav Brain Res 153:21-34
344. Schwienbacher I et al (2002) Dopamine D1 receptors and adenosine A1 receptors in the rat nucleus accumbens regulate motor activity but not prepulse inhibition. Eur J Pharmacol 444:161-169
345. Scott LJ et al (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316:1341-1345
346. Semenova S et al (2008) Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition. Biol Psychiatry 63:98-105
347. Shi L et al (2003) Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 23:297-302
348. Shilling PD, Feifel D (2002) SR146131, a cholecystokinin-A receptor agonist, antagonizes prepulse inhibition deficits produced by dizocilpine and DOI. Psychopharmacology (Berl) 164:285-293
349. Shilling PD et al (2003) The effects of systemic NT69L, a neurotensin agonist, on baseline and drug-disrupted prepulse inhibition. Behav Brain Res 143:7-14
350. Shilling PD et al (2004) Neurotensin agonists block the prepulse inhibition deficits produced by a 5-HT2A and an alpha1 agonist. Psychopharmacology (Berl) 175:353-359
351. Shilling PD et al (2008) Strain differences in gating-disruptive effects of apomorphine: relationship to accumbens gene expression. Abstr Soc Biol Psychiatry (in press)
352. Shishkina GT et al (2004) Influence of neonatal short-term reduction in brainstem alpha2A-adrenergic receptors on receptor ontogenesis, acoustic startle reflex, and prepulse inhibition in rats. Behav Neurosci 118:1285-1292
353. Shoemaker JM et al (2003) Quetiapine produces a prolonged reversal of the sensorimotor gating-disruptive effects of basolateral amygdala lesions in rats. Behav Neurosci 117:136-143
354. Shoemaker JM et al (2005) Prefrontal D1 and ventral hippocampal N-methyl-d-aspartate regulation of startle gating in rats. Neuroscience 135:385-394
355. Shum FW et al (2005) Genetic alteration of anxiety and stress-like behavior in mice lacking CaMKIV. Mol Pain 1:22
356. Sills TL (1999) Amphetamine dose dependently disrupts prepulse inhibition of the acoustic startle response in rats within a narrow time window. Brain Res Bull 48:445-448
357. Silva RC et al (2005) Unilateral electrical stimulation of the inferior colliculus of rats modifies the prepulse modulation of the startle response (PPI): effects of ketamine and diazepam. Behav Brain Res 160:323-330
358. Siuciak JA et al (2007) CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity. Neuropharmacology 52:279-290
359. Slawecki CJ, Ehlers CL (2005) Enhanced prepulse inhibition following adolescent ethanol exposure in Sprague-Dawley rats. Alcohol Clin Exp Res 29:829-836
360. Smith SJ, Lees AJ (1989) Abnormalities of the blink reflex in Gilles de la Tourette syndrome. J Neurol Neurosurg Psychiatry. 52:895-898
361. Sobin C et al (2005a) Associations between prepulse inhibition and executive visual attention in children with the 22q11 deletion syndrome. Mol Psychiatry 10:553-562
362. Sobin C et al (2005b) Lower prepulse inhibition in children with the 22q11 deletion syndrome. Am J Psychiatry 162:1090-1099
363. Sontag TA et al (2003) Removal of short-term isolation stress differentially influences prepulse inhibition in APO-SUS and APO-UNSUS rats. Behav Brain Res 141:171-175
364. Sorenson CA, Swerdlow NR (1982) The effect of tail pinch on the acoustic startle response in rats. Brain Res 247:105-113
365. Sotoyama H et al (2007) Neonatal exposure to epidermal growth factor induces dopamine D(2)-like receptor supersensitivity in adult sensorimotor gating. Psychopharmacology 191:783-792
366. Spencer CM et al (2006) Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins. Hum Mol Genet 15:1984-1994
367. Spielewoy C, Markou A (2004) Strain-specificity in nicotine attenuation of phencyclidine-induced disruption of prepulse inhibition in mice: relevance to smoking in schizophrenia patients. Behav Genet 34:343-354
368. Spooren W et al (2004) Pharmacological and genetic evidence indicates that combined inhibition of NR2A and NR2B subunit containing NMDA receptors is required to disrupt prepulse inhibition. Psychopharmacology (Berl) 175:99-105
369. Stanhope KJ et al (2001) The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the rat. J Pharmacol Exp Ther 299:782-792
370. Stevenson CW, Gratton A (2004) Role of basolateral amygdala dopamine in modulating prepulse inhibition and latent inhibition in the rat. Psychopharmacology 176:139-145
371. Suemaru K et al (2004) Nicotine blocks apomorphine-induced disruption of prepulse inhibition of the acoustic startle in rats: possible involvement of central nicotinic alpha7 receptors. Br J Pharmacol 142:843-850
372. Sugar C et al (2007) Subtyping the group of schizophrenias using neurophysiological endophenotypes. Abstr Soc Neuroscience 226.6
373. Svenningsson P et al (2003) Diverse psychotomimetics act through a common signaling pathway. Science 302:1412-1415
374. Swerdlow NR (1996) Cortico-striatal substrates of cognitive, motor and sensory gating: Speculations and implications for psychological function and dysfunction. In: Panksepp J (ed) Advances in biological psychiatry, vol. 2. JAI Press Inc, Greenwich CT, pp 179-208
375. Swerdlow NR (2005) Much ado about (almost) nothing: response to 'prepulse lost and regained'. Psychopharmacology 179:893-894
376. Swerdlow NR, Geyer MA (1993a) Prepulse inhibition of acoustic startle in rats after lesions of the pedunculopontine nucleus. Behav Neurosci 107:104-117
377. Swerdlow NR, Geyer MA (1993b) Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Pharmacol Biochem Behav 44:741-744
378. Swerdlow NR, Geyer MA (1998) Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizphr Bull 24:285-301
379. Swerdlow et al (1986) Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics. Biol Psychiatry 21:23-33
380. Swerdlow NR et al (1992) The neural substrates of sensorimotor gating of the startle reflex: a review of recent findings and their implications. J Psychopharmacol 6:176-190
381. Swerdlow NR et al (1993a) A preliminary assessment of sensorimotor gating in patients with Obsessive Compulsive Disorder (OCD). Biol Psychiatry 33:298-301
382. Swerdlow NR et al (1993b) Men are more inhibited than women by weak prepulses. Biol Psychiatry 34:253-261
383. Swerdlow NR et al (1994) Assessing the validity of an animal model of sensorimotor gating deficits in schizophrenic patients. Arch Gen Psychiatry 51:139-154
384. Swerdlow NR et al (1995a) Impaired prepulse inhibition of acoustic and tactile startle in patients with Huntington's Disease. J Neurol Neurosurg Psychiat 58:192-200
385. Swerdlow NR et al (1995b) "Normal" personality correlates of sensorimotor, cognitive, and visuospatial gating. Biol Psychiatry 37:286-299
386. Swerdlow NR et al (1997) Changes in sensorimotor inhibition across the menstrual cycle: Implications for neuropsychiatric disorders. Biol. Psychiatry 41:452-460
387. Swerdlow NR et al (1998) Discrepant findings of clozapine effects on prepulse inhibition of startle: is it the route or the rat. Neuropsychopharmacology 18:50-56
388. Swerdlow NR et al (2000a) Animal models of deficient sensorimotor gating: What we know, what we think we know, and what we hope to know soon. Behav Pharmacol 111:185-204
389. Swerdlow NR et al (2000b) Towards understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists. J Neurosci 20:4325-4336
390. Swerdlow NR et al (2001a) Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl) 156:194-215
391. Swerdlow NR et al (2001b) Tactile prepuff inhibition of startle in children with Tourette's syndrome: in search of an "fMRI-friendly" startle paradigm. Biol. Psychiatry 50:578-585
392. Swerdlow NR et al (2001c) Matching strategies for drug studies of prepulse inhibition in humans. Behav Pharmacol. 12:45-52
393. Swerdlow NR et al (2002a) Prestimulus effects on startle magnitude: sensory or motor. Behavioral Neuroscience 116:672-681
394. Swerdlow NR et al (2002b) Prestimulus modification of the startle reflex: Relationship to personality and physiological markers of dopamine function. Biol Psychology 62:17-26
395. Swerdlow NR et al (2002c) Startle gating in rats is disrupted by chemical inactivation but not D2 stimulation of the dorsomedial thalamus. Brain Research 953:246-254
396. Swerdlow NR et al (2003a) Sensitivity to sensorimotor gating-disruptive effects of apomorphine in two outbred parental rat strains and their F1 and N2 progeny. Neuropsychopharmacology 28:226-234
397. Swerdlow NR et al (2003b) Amphetamine effects on prepulse inhibition across species: Replication and parametric extension. Neuropsychopharmacology 28:640-650
398. Swerdlow NR et al (2003c) Memantine effects on startle gating in rats: pretreatments with quetiapine and haloperidol. Society for Neuroscience, Program No. 858.17, Washington, DC
399. Swerdlow NR et al (2003d) Prestimulus modification of the startle reflex: relationship to personality and physiological markers of dopamine function. Biol Psychology 62:17-26
400. Swerdlow NR et al (2004a) Sensitivity to drug effects on prepulse inhibition in inbred and outbred rat strains. Pharmacol Biochem Behav 77:291-302
401. Swerdlow NR et al (2004b) The ventral hippocampal regulation of prepulse inhibition and its disruption by apomorphine in rats are not mediated via the fornix. Neuroscience 123:675-85
402. Swerdlow NR et al (2004c) Weak prepulses inhibit but do not elicit startle in rats and humans. Biol Psychiatry 55:1195-1198
403. Swerdlow NR et al (2004d) Heritable differences in the dopaminergic regulation of sensorimotor gating: II. Temporal, pharmacologic and generational analyses of apomorphine effects on prepulse inhibition. Psychopharmacology 174:452-462
404. Swerdlow NR et al (2005a) Effects of memantine on startle gating in normal adult men. Proc Am Coll Neuropsychopharm, Waikoloa, HI
405. Swerdlow NR et al (2005b) Prepulse inhibition of perceived stimulus intensity: paradigm assessment. Biol Psychology 69:133-147
406. Swerdlow NR et al (2005c) Reduced startle gating after D1 blockade: effects of concomitant D2 blockade. Pharm Biochem Behav 82:293-299
407. Swerdlow NR et al (2006a) Antipsychotic effects on prepulse inhibition in normal 'low gating' humans and rats. Neuropsychopharmacology 31:2011-2021
408. Swerdlow NR et al (2006b) Convergence and divergence in the neurochemical regulation of prepulse inhibition of startle and N40 suppression in rats. Neuropsychopharmacology 31:506-515
409. Swerdlow NR et al (2006c) Forebrain D1 function and sensorimotor gating in rats: effects of D1 blockade, frontal lesions and dopamine denervation. Neurosci Lett 402:40-45
410. Swerdlow NR et al (2006d) Heritable differences in the dopaminergic regulation of behavior in rats: relationship to D2-like receptor G-protein function. Neuropsychopharmacology 31:721-729
411. Swerdlow NR et al (2006e) Separable noradrenergic and dopaminergic regulation of prepulse inhibition in rats: implications for predictive validity and Tourette Syndrome. Psychopharmacology (Berl) 186:246-254
412. Swerdlow NR et al (2006f) Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function. Arch Gen Psychiatry 63:1325-1335
413. Swerdlow NR et al (2006g) The "low gating" phenotype in rats: antipsychotic sensitivity, heritability and sex differences. Biol Psychiatry 59:220S
414. Swerdlow NR et al (2007) Multi-site studies of acoustic startle and prepulse inhibition in humans: Initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia. Schizophrenia Research 92:237-251
415. Swerdlow NR et al (2008) A novel rat strain with enhanced sensitivity to the effects of dopamine agonists on startle gating. Pharmacol Biochem Behav 88:280-290
416. Szumlinski KK et al (2005) Behavioral and neurochemical phenotyping of Homer1 mutant mice: possible relevance to schizophrenia. Genes Brain Behav 4:273-288
417. Tadros MG et al (2005) Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington's disease phenotype. Pharmacol Biochem Behav 82:574-582
418. Takahashi M et al (2006) Sustained brain-derived neurotrophic factor up-regulation and sensorimotor gating abnormality induced by postnatal exposure to phencyclidine: comparison with adult treatment. J Neurochem 99:770-780
419. Takahashi K et al (2007) Neural circuits containing pallidotegmental GABAergic neurons are involved in the prepulse inhibition of the startle reflex in mice. Biol Psychiatry 62:148-157
420. Takeuchi T et al (2001) Roles of the glutamate receptor epsilon2 and delta2 subunits in the potentiation and prepulse inhibition of the acoustic startle reflex. Eur J Neurosci 14:153-160
421. Tan SE (2003) Prenatal amphetamine exposure alters behavioral reactivity to amphetamine in rats. Neurotoxicol Teratol 25:579-585
422. Tanaka K et al (2006) Psychostimulant-induced attenuation of hyperactivity and prepulse inhibition deficits in Adcyap1-deficient mice. J Neurosci 26:5091-5097
423. Taniguchi T et al (2005) Transgenic mice expressing mutant (N279K) human tau show mutation dependent cognitive deficits without neurofibrillary tangle formation. FEBS Lett 579:5704-5712
424. Tejkalova H et al (2007) Does neonatal brain ischemia induces schizophrenia-like behaviour in young adult rats? Physiol Res 56:815-823
425. Tenn CC et al (2003) Amphetamine-sensitized animals show a sensorimotor gating and neurochemical abnormality similar to that of schizophrenia. Schizophr Res 64:103-114
426. Terry AV Jr et al (2007) Chronic, intermittent exposure to chlorpyrifos in rats: protracted effects on axonal transport, neurotrophin receptors, cholinergic markers, and information processing. J Pharmacol Exp Ther 322:1117-1128
427. Thomsen M et al (2007) Decreased prepulse inhibition and increased sensitivity to muscarinic, but not dopaminergic drugs in M5 muscarinic acetylcholine receptor knockout mice. Psychopharmacology (Berl) 192:97-110
428. Tremolizzo L et al (2005) Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice. Biol Psychiatry 57:500-509
429. Tsai G et al (2004) Gene knockout of glycine transporter 1: characterization of the behavioral phenotype. Proc Natl Acad Sci USA 101:8485-8490
430. Uehara T et al (2007) Effect of prefrontal cortex inactivation on behavioral and neurochemical abnormalities in rats with excitotoxic lesions of the entorhinal cortex. Synapse 61:391-400
431. Ukai M, Okuda A (2003) Endomorphin-1, an endogenous mu-opioid receptor agonist, improves apomorphine-induced impairment of prepulse inhibition in mice. Peptides 24:741-744
432. Umeda K et al (2006) Effects of mood stabilizers on the disruption of prepulse inhibition induced by apomorphine or dizocilpine in mice. Eur J Pharmacol 553:157-162
433. Valls-Sole J et al (2004) Abnormalities of prepulse inhibition do not depend on blink reflex excitability: a study in Parkinson's disease and Huntington's disease. Clin Neurophysiol 115:1527-1536
434. van den Buuse M (2004) Prepulse inhibition of acoustic startle in spontaneously hypertensive rats. Behav Brain Res 154:331-337
435. van den Buuse M, Gogos A (2007) Differential effects of antipsychotic drugs on serotonin-1A receptor-mediated disruption of prepulse inhibition. J Pharmacol Exp Ther 320:1224-1236
436. van den Buuse M et al (2003) Prepulse inhibition of acoustic startle in aromatase knock-out mice: effects of age and gender. Genes Brain Behav 2:93-102
437. van den Buuse M et al (2004) Effect of adrenalectomy and corticosterone replacement on prepulse inhibition and locomotor activity in mice. Br J Pharmacol 142:543-550
438. van den Buuse M et al (2005a) Enhanced effect of dopaminergic stimulation on prepulse inhibition in mice deficient in the alpha subunit of G(z). Psychopharmacology 183:358-367
439. van den Buuse M et al (2005b) Reduced effects of amphetamine on prepulse inhibition of startle in gastrin-deficient mice. Neurosci Lett 373:237-242
440. van der Elst MC et al (2006) Cocaine strongly reduces prepulse inhibition in apomorphine-susceptible rats, but not in apomorphine-unsusceptible rats: regulation by dopamine D2 receptors. Behav Brain Res 175:392-398
441. van der Elst MC et al (2007) Differences in the cellular mechanism underlying the effects of amphetamine on prepulse inhibition in apomorphine-susceptible and apomorphine-unsusceptible rats. Psychopharmacology (Berl) 190:93-102
442. van der Linden D et al (2006) Disrupted sensorimotor gating due to mental fatigue: preliminary evidence. Int J Psychophysiol 62:168-174
443. Van Raamsdonk JM et al (2005) Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease. J Neurosci 25:4169-4180
444. Vanover KE et al (2006) Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2- methylpropylo xy)phenylmethyl) carbamide (2R,3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine(2A) receptor inverse agonist. J Pharmacol Exp Ther 317:910-918
445. Varty GB et al (2006) Isolation rearing of mice induces deficits in prepulse inhibition of the startle response. Behav Brain Res 169:162-167
446. Venables P (1964) Input dysfunction in schizophrenia. Prog Exp Pers Res 1:1-47
447. Vollenweider FX et al (1999) Opposite effects of 3,4- methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans. Psychopharmacology (Berl) 143:365-372
448. Vollenweider FX et al (2006) Clozapine enhances prepulse inhibition in healthy humans with low but not with high prepulse inhibition levels. Biol Psychiatry 60:597-603
449. Volz M et al (2003) Temporal course of emotional startle modulation in schizophrenia patients. Int J Psychophysiol 49:123-137
450. von Goethe JW (1779) The sorcerer's apprentice
451. Wang C et al (2003a) Blockade of phencyclidine-induced cortical apoptosis and deficits in prepulse inhibition by M40403, a superoxide dismutase mimetic. J Pharmacol Exp Ther 304:266-271
452. Wang JH et al (2003b) Reduced startle habituation and prepulse inhibition in mice lacking the adenosine A2A receptor. Behav Brain Res 143:201-207
453. Wardas J et al (2003) Influence of CGS 21680, a selective adenosine A(2A) agonist, on the phencyclidine-induced sensorimotor gating deficit and motor behaviour in rats. Psychopharmacology (Berl) 168:299-306
454. Watanabe Y et al (2004) Neonatal impact of leukemia inhibitory factor on neurobehavioral development in rats. Neurosci Res 48:345-353
455. Weber M, Swerdlow NR (2008) Rat strain differences in startle gating-disruptive effects of apomorphine occur with both acoustic and visual prepulses. Pharmacol Biochem Behav 88:306-311
456. Weike AI et al (2000) Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients. Biol. Psychiatry 47:61-70
457. Weike AI et al (2001) Sensorimotor gating and attitudes related to schizotypal proneness. Psychol Rep 88:1035-1045
458. Weil ZM et al (2006) Melatonin receptor (MT1) knockout mice display depression-like behaviors and deficits in sensorimotor gating. Brain Res Bull 68:425-429
459. Weiss IC et al (1999) Isolation rearing-induced disruption of prepulse inhibition: further evidence for fragility of the response. Behav Pharmacol 10:139-149
460. Weiss IC et al (2000) Strain differences in the isolation-induced effects on prepulse inhibition of the acoustic startle response and on locomotor activity. Behav Neurosci 114:364-373
461. Wiedholz LM et al (2008) Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopaminergia and 'schizophrenia-related' behaviors. Mol Psychiatry (in press)
462. Wilmouth CE, Spear LP (2006) Withdrawal from chronic nicotine in adolescent and adult rats. Pharmacol Biochem Behav 85:648-657
463. Wolf R et al (2007) Acute or subchronic clozapine treatment does not ameliorate prepulse inhibition (PPI) deficits in CPB-K mice with low levels of hippocampal NMDA receptor density. Psychopharmacology (Berl) 194:93-102
464. Wolinsky TD et al (2007) The trace amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia. Genes Brain Behav 6:628-639
465. Wynn JK et al (2004) Prepulse facilitation and prepulse inhibition in schizophrenia patients and their unaffected siblings. Biol Psychiatry 55:518-523
466. Wynn JK et al (2005) Sensorimotor gating, orienting and social perception in schizophrenia. Schizophr Res 73:319-325
467. Wynn JK et al (2007) Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: A double-blind, randomized controlled trial. Schizophr Res 95:134-142
468. Yamashita M et al (2006) Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout mice. Neuropsychopharmacology 31:2132-2139
469. Yee BK et al (2004) Apomorphine-induced prepulse inhibition disruption is associated with a paradoxical enhancement of prepulse stimulus reactivity. Neuropsychopharmacology 29:240-248
470. Yee BK et al (2005) A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction. Proc Natl Acad Sci USA 102:17154-17159
471. Yeomans JS et al (2006) Midbrain pathways for prepulse inhibition and startle activation in rat. Neuroscience 142:921-929
472. Yukawa K et al (2005) Reduced prepulse inhibition of startle in STAT6-deficient mice. Int J Mol Med 16:673-675
473. Zajaczkowski W et al (2003) A competitive antagonist of NMDA receptors CGP 40116 attenuates experimental symptoms of schizophrenia evoked by MK-801. Pol J Pharmacol 55:703-711
474. Zhang WN et al (2002a) Effects of hippocampal N-methyl-d-aspartate infusion on locomotor activity and prepulse inhibition: differences between the dorsal and ventral hippocampus. Behav Neurosci 116:72-84
475. Zhang WN et al (2002b) Prepulse inhibition in rats with temporary inhibition/inactivation of ventral or dorsal hippocampus. Pharmacol Biochem Behav 73:929-940
476. Zhang M et al (2006) Effect of dopamine D3 antagonists on PPI in DBA/2J mice or PPI deficit induced by neonatal ventral hippocampal lesions in rats. Neuropsychopharmacology 31:1382-1392
477. Zhang L et al (2007a) Minocycline attenuates hyperlocomotion and prepulse inhibition deficits in mice after administration of the NMDA receptor antagonist dizocilpine. Neuropsychopharmacology 32:2004-2010
478. Zhang M et al (2007b) Effects of antipsychotics and selective D(3) antagonists on PPI deficits induced by PD 128907 and apomorphine. Behav Brain Res 182:1-11